ConductScience.org, home

Paper978183

Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action.

Palese P and 1 other. J Gen Virol, 1976. Cited by 264 papers, by iCite.

Cite this record

ConductScience Library. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. Papers, record 978183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/978183

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action.
PubMed
Journal
J Gen Virol
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
264
iCite
Relative citation ratio, by iCite
5.91
iCite
Revised in PubMed
2006-11-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Palese PP
2Compans RWR W

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Influenza A virusMajor topic
NeuraminidaseMajor topic
Sialic AcidsMajor topic
Virus ReplicationMajor topic
Cell Line
Hemagglutinins, Viral
Hydroxides
Mutation
Temperature

Source PubMed

Download CSV of topics

Cited by146

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 264 citations.

PMIDTitleJournalYearIn PapersSource
42339829ELISA-based quantification of neuraminidase in commercial influenza vaccines using virus-derived reference antigens.Microbiol Spectr2026https://conductscience.org/library/papers/42339829PubMed
42294863Immunization with N2 neuraminidase can protect mice against a heterologous influenza A virus challenge even in the absence of cross-NA inhibiting antibodies.mSphere2026https://conductscience.org/library/papers/42294863PubMed
42180550A novel entry inhibitor targeting the stalk domain of the hemagglutinin of H1N1.Acta Pharm Sin B2026https://conductscience.org/library/papers/42180550PubMed
42119981INAAC: An affinity chromatography strategy enabling characterization and quantification of influenza neuraminidase antigens in vaccines.J Biol Chem2026https://conductscience.org/library/papers/42119981PubMed
41904223Non-propagating RNA virus-vectored HA/NA vaccine prevents shedding of antigen-drifted H1N1 influenza virus in pigs.NPJ Vaccines2026https://conductscience.org/library/papers/41904223PubMed
41720824Spatial localization of avian and human influenza A virus receptors in male and female bovine reproductive tissues.Sci Rep2026https://conductscience.org/library/papers/41720824PubMed
41713404Pathogenesis and Transmission of a Reassorted H1 Influenza A Virus Detected in North American Swine.Influenza Other Respir Viruses2026https://conductscience.org/library/papers/41713404PubMed
41705853Neuraminidase of influenza A viruses induces global desialylation of host cells via its intracellular function.Microbiol Spectr2026https://conductscience.org/library/papers/41705853PubMed
41503581Improved cross-protection and immunity against influenza A virus in mice using a novel mRNA vaccine with optimized design of RNA sequence.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/41503581PubMed
40824089N-linked glycans on the stalk of influenza virus neuraminidase promote functional tetramer formation by compensating for local hydrophobicity.J Virol2025https://conductscience.org/library/papers/40824089PubMed
39730318Molecular Evolution of the H5 and H7 Highly Pathogenic Avian Influenza Virus Haemagglutinin Cleavage Site Motif.Rev Med Virol2025https://conductscience.org/library/papers/39730318PubMed
39645432A neuraminidase-based inactivated influenza virus vaccine significantly reduced virus replication and pathology following homologous challenge in swine.Vaccine2025https://conductscience.org/library/papers/39645432PubMed
39113298The Development History, Structural Composition, and Functions of Influenza Viruses and the Progress of Influenza Virus Inhibitors in Clinics and Clinical Trials.Mini Rev Med Chem2025https://conductscience.org/library/papers/39113298PubMed
38915760Natural variation in neuraminidase activity influences the evolutionary potential of the seasonal H1N1 lineage hemagglutinin.Virus Evol2024https://conductscience.org/library/papers/38915760PubMed
38784667Next generation single-domain antibodies against respiratory zoonotic RNA viruses.Front Mol Biosci2024https://conductscience.org/library/papers/38784667PubMed
38400091The Influenza A Virus Replication Cycle: A Comprehensive Review.Viruses2024https://conductscience.org/library/papers/38400091PubMed
38362681Progress of Influenza Viruses and Inhibitors.Curr Med Chem2025https://conductscience.org/library/papers/38362681PubMed
38250908Development of Cross-Reactive Live Attenuated Influenza Vaccine Candidates against Both Lineages of Influenza B Virus.Vaccines (Basel)2024https://conductscience.org/library/papers/38250908PubMed
37800945Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner.J Virol2023https://conductscience.org/library/papers/37800945PubMed
37376638Roles and Mechanisms of NLRP3 in Influenza Viral Infection.Viruses2023https://conductscience.org/library/papers/37376638PubMed

See all 146 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NEU14758PubTator's text mininghttps://conductscience.org/library/genes/4758

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/978183

GET https://conductscience.org/api/papers/v1/978183/cited_by?page=2